Journal List > Korean J Lab Med > v.28(6) > 1011510

Kim, Kim, Cho, Kim, Kim, Nam, Kim, Bae, and Cho: Evaluation of Automated Architect Syphilis TP as a Diagnostic Laboratory Screening Test for Syphilis

Abstract

Background

The aim of the study was to establish a new syphilis test algorithm using Architect Syphilis TP (Abbott Japan, Japan: AST), a fully automated treponemal antibody test, as a screening test in a university hospital laboratory. We evaluated performance characteristics of AST in various patient groups.

Methods

A total of 1,357 serum samples obtained from patients at a university hospital from June to August, 2008 were categorized into checkup, preoperative, other diseases, diagnosis (clinically suspected of syphilis), and follow up groups. We compared the results of AST with those of RPR (N=1,276) or Treponema pallidum hemagglutination assay (TPHA, N=81). Samples with discrepant results between RPR or TPHA and AST were retested by fluorescent treponemal antibody absorption test (FTA-ABS) and all patients’ clinical records were thoroughly reviewed.

Results

The positive rate of AST was significantly higher than that of RPR in preoperative and other diseases groups and was the same as that of RPR in diagnosis group. There were no significant differences in check up and follow up groups. The results of AST showed 97.4% (1,243/1,276) and 97.5% (79/81) concordance rates with those of RPR and TPHA, respectively. Among 26 RPR-AST discrepant and FTA-ABS confirmed cases, there were 20 RPR false-negatives, 4 RPR false-positives, 1 AST false-negative, and 1 AST false-positive.

Conclusions

Based on the results and literature review, we established a new syphilis test algorithm using AST as a screening test, which would be helpful for detection of more syphilis patients including latent infections.

REFERENCES

1.Philip SS., Jacobs RA. Spirochetal Infections. McPhee SJ., Papadakis MA, et al. Current medical diagnosis & treatment. 2009. http://www.accessmedicine.com/content.aspx?aID=18592. (last opened on Nov 2008).
2.Korea Centers for Disease Control and Prevention. Disease web statistics system. http://stat.cdc.go.kr/Index_List.aspx. (updated on Oct 2008).
3.Jang HC., Cho JH., Park WB., Lee KD., Lee CS., Kim HB, et al. Outbreak of primary and secondary syphilis among HIV sero-positive patients in Korea. Infection and Chemotherapy. 2004. 36:366–72. (장희창, 조재현, 박완범, 이기덕, 이창섭, 김홍빈 등. 인간 면역부전 바이러스(HIV) 감염자 사이에서의 1기 및 2기 매독의 유행. 감염과 화학요법 2004;36: 366-72.).
4.Lee SH., Suh DH., Cho KH., Eun HC. Two cases of unusual manifestations of secondary syphilis accompanied by human immunodeficiency virus infection. Korean J Dermatol. 2003. 41:354–9. (이승호, 서대헌, 조광현, 은희철. Human immunodeficiency virus 감염에 동반된 비전형적인 피부소견을 보인 2기 매독 2예. 대한피부과학회지 2003;41: 354-9.).
5.Kang SK., Kim ES., Lee MW., Choi JH., Sung KJ., Moon KC, et al. Two cases of secondary syphilis accompanied by acquired immunodeficiency syndrome. Korean J Dermatol. 2002. 40:428–32. (강숙경, 김은성, 이미우, 최지호, 성경제, 문기찬등. 후천성면역결핍증에동반된 2기매독 2예. 대한피부과학회지 2002;40: 428-32.).
6.Song EY., Yang JS., Chae SL., Kim S., Choi YS., Cha YJ. Current status of external quality assessment of syphilis test in Korea. Korean J Lab Med. 2008. 28:207–13. (송은영, 양주석, 채석래, 김세림, 최영숙, 차영주. 국내 매독검사의 외부신빙도조사 현황. 대한진단검사의학회지 2008;28: 207-13.).
crossref
7.Pope V., Ari MD., Schriefer ME., Levett PN. Immunologic methods for diagnosis of spirochetal disease. Detrick B, Hamilton RG, editors. Manual of molecular and clinical laboratory immunology. 7th ed.Washington DC: ASM Press;2006. p. 477–92.
8.Goh BT., van Voorst Vader PC. European guideline for the management of syphilis. Int J STD AIDS. 2001. 12(S):S14–26.
crossref
9.Kim YH., Kim HR., Park C., Seo MY., Park J. Comparative sensitivity of Architect syphilis TP with other antibody tests. J Lab Med Qual Assur. 2008. 30:217–21. (김영휴, 김형락, 박철, 서민영, 박준석. Architect Syphilis TP를 이용한 매독감염항체 검사 민감도의 비교평가. 임상검사와정도관리 2008;30: 217-21.).
10.Yoshioka N., Deguchi M., Kagita M., Kita M., Watanabe M., Asari S, et al. Evaluation of a chemiluminescent microparticle immunoassay for determination of Treponema pallidum antibodies. Clin Lab. 2007. 53:597–603.
11.Egglestone SI., Turner AJ. Serological diagnosis of syphilis. PHLS syphilis serology working group. Commun Dis Public Health. 2000. 3:158–62.
12.Young H. Guidelines for serological testing for syphilis. Sex Transm Infect. 2000. 76:403–5.
crossref
13.U.S. Food and Drug Administration. Cleared tests for Treponema pallidum (Syphilis). http://www.fda.gov/CBER/tissue/prod.htm#syp. (Updated on Aug 2008).
14.Centers for Disease Control and Prevention (CDC). Syphilis testing algorithms using treponemal tests for initial screening–four laboratories, New York city, 2005-2006. MMWR Morb Mortal Wkly Rep. 2008. 57:872–5.
15.Huh HJ., Lee KK., Kim ES., Chae SL. Analysis of positive results in Mediace rapid plasma reagin and Treponema pallidum latex agglutination as the automated syphilis test. Korean J Lab Med. 2007. 27:324–9. (허희진, 이교관, 김의석, 채석래. 자동화 매독검사인 Mediace Rapid Plasma Reagin과 Treponema pallidum Latex Agglutination 양성결과분석. 대한진단검사의학회지 2007;27: 324-9.).
16.Centers for disease control and prevention, Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006. 55:1–94.
17.Hagedorn HJ., Kraminer-Hagedorn A., De Bosschere K., Hulstaert F., Pottel H., Zrein M. Evaluation of INNO-LIA syphilis assay as a confirmatory test for syphilis. J Clin Microbiol. 2002. 40:973–8.
crossref
18.Backhouse JL., Nesteroff SI. Treponema pallidum western blot: comparison with the FTA-ABS test as a confirmatory test for syphilis. Diagn Microbiol Infect Dis. 2001. 39:9–14.

Fig. 1.
Quantitative correlation plot between TPHA titer and Architect Syphilis TP S/CO. R=0.802 (P<0.001).
kjlm-28-475f1.tif

Abbreviations: TPHA, Treponema pallidum hemagglutination assay; S/CO, signal to cut-off ratio.

Fig. 2.
Syphilis testing algorithm using Architect Syphilis TP for initial screening.
kjlm-28-475f2.tif

, The patients who are clinically suspicious of syphilis or other sexually transmitted diseases.

Table 1.
Age distribution of patients with requests for RPR
Group Male Female
N (692) Median Range N (584) Median Range
Check up 182 46 17-79 150 46 25-78
Pre-op 239 47 6-88 208 50 5-87
Other diseases 263 48 2-85 211 43 3-87
Diagnosis 3 53 18-73 12 40 19-73
Follow-up 5 34 24-51 3 38 35-38

, Check up, visitors for health check up; Pre-op, patients for preoperative screening test; Other disease, patients with various diseases to rule out syphilis; Diagnosis, patients who are highly suspicious of syphilis; Follow up, confirmed syphilis patients with follow-up. Abbreviations: N, number; RPR, rapid plasma reagin.

Table 2.
Number and percentage for reactive results in each group by RPR and Architect Syphilis TP (AST)
Group Total N (%) of RPR reactive N (%) of AST reactive P
Check up 332 1 (0.3) 5 (1.5) 0.125
Pre-op 447 5 (1.1) 15 (3.4) 0.021
Other diseases 474 19 (4.0) 27 (5.7) 0.039
Diagnosis 15 8 (53.3) 8 (53.3) 1.000
Follow up 8 8 (100) 7 (87.5)  
Total 1,276 41 (3.2) 62 (4.8) 0.000

, See Table 1;

, McNemar Test.

Abbreviations: See Table 1

Table 3.
Comparison of RPR and Architect Syphilis TP results
RPR Architect Syphilis TP Total
Reactive Non-reactive
Reactive 35 6 41
Non-reactive 27 1,208 1,235
Total 62 1,214 1,276

Abbreviation: RPR, rapid plasma reagin.

Table 4.
Comparison of TPHA and Architect Syphilis TP results
TPHA Architect Syphilis TP Total
Reactive Non-reactive
Reactive 24 0 24
Non-reactive 2 55 57
Total 26 55 81

, The results of FTA-ABS were positive and their clinical diagnoses were bladder tumor and lung destruction due to tuberculosis, respectively.

Abbreviation: TPHA, Treponema pallidum hemagglutination assay.

Table 5.
Clinical diagnosis of the cases with discrepant results between RPR and Architect syphilis TP
Decision Group N STS Clinical diagnosis
RPR false negative (20) Check up 4 NRRN Flat adenoma of stomach; eosinophilia; healthy status; benign prostatic hyperplasia
  Pre-op 10 NRRN Carpal tunnel syndrome; burst fracture of T12; compression fracture of T12; osteoarthritis of both knees; septic bursitis; avascular necrosis of femoral head; sigmoid colon cancer; right shoulder rotator cuff tear; fibrous dysplasia of right lower limb; coronary artery occlusive disease
  Other diseases 5 NRRN Concussion with periorbital contusion; brain & lung abscess; prostate cancer; conjunctivitis; acute HIV infection syndrome
    1 NRRR Recurrent oral aphthae
RPR false positive (4) Pre-op 2 RNNN Hyphema; impacted teeth
  Other diseases 2 RNNN Normal pregnancy; glaucoma
AST false negative (1) Follow up 1 RNRR Primary syphilis
AST false positive (1) Other diseases 1 NRNN Angioedema§
Pending (7) Pre-op 4 NRXX Prostate cancer; adenomyosis; impacted teeth; intraheptic duct stone
    1 RNXX Cervical spondylosis
  Other diseases 2 NRXX Chronic renal failure; condyloma accuminatum

, See Table 1;

, Results of RPR, AST, FTA-ABS IgG, and FTA-ABS IgM in order;

, Syphilis patient with genital ulcers;

§ , Angioedema patient without any symptoms of syphilis.

Abbreviations: STS, serologic tests for syphilis; N, nonreactive; R, reactive; X, not done; RPR, rapid plasma reagin; AST, Architect Syphilis TP.

TOOLS
Similar articles